CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: comment on the article by Moore et al.
Jacob M
JM
Van Laar
Steven Z
SZ
Pavletic
D018952:Antigens, CD34 / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D013601:T-Lymphocytes / Q000187:drug effects; D019172:Transplantation Conditioning
D018952:Antigens, CD34; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide